(Q24316444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

SNAP-23 and VAMP-3 contribute to the release of IL-6 and TNFα from a human synovial sarcoma cell line (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Sanjay V Boddul

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jianghui Meng

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

James Oliver Dolly

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

13 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

750-765

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

Arthritis and pain. Current approaches in the treatment of arthritic pain

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Osteoarthritis year 2011 in review: biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cells of the synovium in rheumatoid arthritis. Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cytokines in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Fibroblast-like synovial cells from normal and inflamed knee joints differently affect the expression of pain-related receptors in sensory neurones: a co-culture study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Human SCAMP5, a novel secretory carrier membrane protein, facilitates calcium-triggered cytokine secretion by interaction with SNARE machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

SNAREing immunity: the role of SNAREs in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

An update on the neurologic applications of botulinum toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Retargeted clostridial neurotoxins as novel agents for treating chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cytokine secretion in macrophages and other cells: pathways and mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

T cells use two directionally distinct pathways for cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

A role for the phagosome in cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Pathogenesis of rheumatoid arthritis: targeting cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

SV2 is the protein receptor for botulinum neurotoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Pathophysiology and treatment of pain in joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Cytokine release from innate immune cells: association with diverse membrane trafficking pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Pathways for cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

The t-SNARE syntaxin 4 is regulated during macrophage activation to function in membrane traffic and cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

SNARE complex formation is triggered by Ca2+ and drives membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

The synaptic vesicle proteins SV2, synaptotagmin and synaptophysin are sorted to separate cellular compartments in CHO fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Pain behavior measures to quantitate joint pain and response to neurotoxin treatment in murine models of arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Long term effects of intra-articular botulinum toxin A for refractory joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Engineering botulinum neurotoxin to extend therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

SV2 mediates entry of tetanus neurotoxin into central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Repeat Injections of Intra-Articular Botulinum Toxin A for the Treatment of Chronic Arthritis Joint Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

SV2A and SV2C contain a unique synaptotagmin-binding site

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Pathogenesis of arthritis: recent research progress

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Synaptic core complex of synaptobrevin, syntaxin, and SNAP25 forms high affinity alpha-SNAP binding site

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12620

7 January 2021

Identifiers

DOI

10.1111/FEBS.12620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24373201%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference